Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives

References

• Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537–1541. doi:10.1001/archderm.141.12.153716365254
   PubMedGoogle Scholar
• Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633–636. doi:10.1111/j.1365-2133.2009.09593.x19922529
   PubMed Web of Science ®Google Scholar
• Yamamah GA, Emam HM, Abdelhamid MF, et al. Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt. Int J Dermatol. 2012;51(10):1180–1185. doi:10.1111/j.1365-4632.2012.05475.x22834561
   PubMed Web of Science ®Google Scholar
• Chang YT, Chen TJ, Liu PC, et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol. 2009;89(3):262–266. doi:10.2340/00015555-064219479122
   PubMed Web of Science ®Google Scholar
• Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979–987.19962785
   PubMed Web of Science ®Google Scholar
• Wu JJ, Black MH, Smith N, Porter AH, Jacobsen SJ, Koebnick C. Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California. J Am Acad Dermatol. 2011;65(5):957–964. doi:10.1016/j.jaad.2010.09.00521306784
   PubMed Web of Science ®Google Scholar
• Burden-Teh E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R. The epidemiology of childhood psoriasis: a scoping review. Br J Dermatol. 2016;174(6):1242–1257. doi:10.1111/bjd.1450726928555
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–178. doi:10.1046/j.1525-1470.2000.01746.x10886746
   PubMed Web of Science ®Google Scholar
• Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46(6):867–873. doi:10.1067/mjd.2002.12047012063483
   PubMed Web of Science ®Google Scholar
• Bonigen J, Phan A, Hadj-Rabia S, et al. Impact de l’âge et du sexe sur les aspects cliniques et épidémiologiques du psoriasis de l’enfant. Données d’une étude transversale, multicentrique française. Ann Dermatol Venereol. 2016;143(5):354–363. doi:10.1016/j.annder.2016.02.00626969479
   PubMed Web of Science ®Google Scholar
• Mercy K, Kwasny M, Cordoro KM, et al. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013;30(4):424–428. doi:10.1111/pde.1207223360462
   PubMed Web of Science ®Google Scholar
• Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18(3):188–198. doi:10.1046/j.1525-1470.2001.018003188.x11437997
   PubMed Web of Science ®Google Scholar
• Al-Mutairi N, Manchanda Y, Nour-Eldin O. Nail changes in childhood psoriasis: a study from Kuwait. Pediatr Dermatol. 2007;24(1):7–10. doi:10.1111/j.1525-1470.2007.00324.x17300641
   PubMed Web of Science ®Google Scholar
• Mahé E, Beauchet A, Bodemer C, et al. Psoriasis and obesity in French children: a case-control, multicentre study. Br J Dermatol. 2015;172(6):1593–1600. doi:10.1111/bjd.1350725363889
   PubMed Web of Science ®Google Scholar
• Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149(2):166–176. doi:10.1001/jamadermatol.2013.107823560297
   PubMed Web of Science ®Google Scholar
• Badaoui A, Tounian P, Mahé E. Psoriasis and metabolic and cardiovascular comorbidities in children: A systematic review. Arch Pediatr. 2019;26(2):86–94. doi:10.1016/j.arcped.2018.12.00530638928
   PubMed Web of Science ®Google Scholar
• Phan K, Lee G, Fischer G. Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: systematic review and meta-analysis. Pediatr Dermatol. 2020;37(4):661–669. doi:10.1111/pde.1420832436322
   PubMed Web of Science ®Google Scholar
• Guidolin L, Borin M, Fontana E, Caroppo F, Piaserico S, Fortina AB. Central obesity in children with psoriasis. Acta Derm Venereol. 2018;98(2):282–283. doi:10.2340/00015555-281629048098
   PubMed Web of Science ®Google Scholar
• Tounian P. Conséquences à l’âge adulte de l’obésité de l’enfant. Arch Pediatr. 2007;14(6):718–720. doi:10.1016/j.arcped.2007.02.04317419027
   PubMed Web of Science ®Google Scholar
• Ko SH, Chi CC, Yeh ML, Wang SH, Tsai YS, Hsu MY. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019;7(7):CD011972.31309536
   PubMed Web of Science ®Google Scholar
• Caroppo F, Ventura L, Belloni Fortina A. High blood pressure in normal-weight children with psoriasis. Acta Derm Venereol. 2019;99(3):329–330. doi:10.2340/00015555-307630328469
   PubMed Web of Science ®Google Scholar
• Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704. doi:10.1001/jamadermatol.2017.049928514463
   PubMed Web of Science ®Google Scholar
• Mahé E. Childhood psoriasis. Eur J Dermatol. 2016;26(6):537–548. doi:10.1684/ejd.2016.293227900946
   PubMed Web of Science ®Google Scholar
• Mahé E, Maccari F, Ruer-Mulard M, et al. Psoriasis de l’enfant vu en milieu libéral: les aspects cliniques et épidémiologiques diffèrent des données habituellement publiées. Ann Dermatol Venereol. 2019;146(5):354–362. doi:10.1016/j.annder.2019.01.02430954294
   PubMed Web of Science ®Google Scholar
• Bronckers IMGJ, Maatkamp M, Kievit W, van de Kerkhof PCM, de Jong EMGJ, Seyger MMB. The association of scalp psoriasis with overall psoriasis severity and koebnerization in children: cross-sectional findings from the Dutch child-capture registry. Br J Dermatol. 2019;181(5):1099–1101. doi:10.1111/bjd.1816831127952
   PubMed Web of Science ®Google Scholar
• Pourchot D, Bodemer C, Phan A, et al. Nail psoriasis: a systematic evaluation in 313 children with psoriasis. Pediatr Dermatol. 2017;34(1):58–63. doi:10.1111/pde.1302827873356
   PubMed Web of Science ®Google Scholar
• Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheumatol. 2016;68(4):915–923. doi:10.1002/art.3949426555117
   PubMed Web of Science ®Google Scholar
• Meneghetti TC, Padilha TMH, Azevedo VF, Cat MNL, Sarolli BMS, de Carvalho VO. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis. Adv Rheumatol. 2020;60(1):33. doi:10.1186/s42358-020-00136-632552795
   PubMedGoogle Scholar
• Burden-Teh E, Thomas KS, Rangaraj S, Cranwell J, Murphy R. Early recognition and detection of juvenile psoriatic arthritis: a call for a standardized approach to screening. Clin Exp Dermatol. 2017;42(2):153–160. doi:10.1111/ced.1301028044348
   PubMed Web of Science ®Google Scholar
• Coates LC, Aslam T, Al Balushi F, et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013;168(4):802–807. doi:10.1111/bjd.1219023311587
   PubMed Web of Science ®Google Scholar
• Randa H, Todberg T, Skov L, Larsen LS, Zachariae R. Health-related quality of life in children and adolescents with psoriasis: a systematic review and meta-analysis. Acta Derm Venereol. 2017;97(5):555–563. doi:10.2340/00015555-260027983745
   PubMed Web of Science ®Google Scholar
• Van Geel MJ, Maatkamp M, Oostveen AM, et al. Comparison of the dermatology life quality index and the children’s dermatology life quality index in assessment of quality of life in patients with psoriasis aged 16–17 years. Br Dermatol. 2016;174(1):152–157. doi:10.1111/bjd.14163
   PubMed Web of Science ®Google Scholar
• Randa H, Khoury LR, Grønborg TK, Lomholt JJ, Skov L, Zachariae R. Development and preliminary validation of the adolescent psoriasis quality of life instrument: a disease-specific measure of quality of life in adolescents with psoriasis. Br J Dermatol. 2020;183(1):96–104. doi:10.1111/bjd.1871931743420
   PubMed Web of Science ®Google Scholar
• de Jager ME, de Jong EM, Meeuwis KA, van de Kerkhof PC, Seyger MM. No evidence found that childhood onset of psoriasis influences disease severity, future body mass index or type of treatments used. J Eur Acad Dermatol Venereol. 2010;24(11):1333–1339. doi:10.1111/j.1468-3083.2010.03645.x20337819
   PubMed Web of Science ®Google Scholar
• Mahé E, Maccari F, Beauchet A, et al. Childhood onset psoriasis: association with future cardiovascular and metabolic comorbidities. Br J Dermatol. 2013;169(4):889–895. doi:10.1111/bjd.1244123937622
   PubMed Web of Science ®Google Scholar
• Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol. 1988;118(2):195–201. doi:10.1111/j.1365-2133.1988.tb01774.x3348965
   PubMed Web of Science ®Google Scholar
• Bilgic A, Ö B, Akış HK, Eskioğlu F, Kılıç EZ. Psychiatric symptoms and health-related quality of life in children and adolescents with psoriasis. Pediatr Dermatol. 2010;27(6):614–617. doi:10.1111/j.1525-1470.2010.01195.x21078106
   PubMed Web of Science ®Google Scholar
• Carter-Pokras OD, Bugbee BA, Gold RS, et al. Utilizing student health and academic data: a county-level demonstration project. Health Promot Pract. 2019. doi:10.1177/1524839919862796
   Web of Science ®Google Scholar
• Zink A, Herrmann M, Fischer T, et al. Addiction: an underestimated problem in psoriasis health care. J Eur Acad Dermatol Venereol. 2017;31(8):1308–1315. doi:10.1111/jdv.1420428281329
   PubMed Web of Science ®Google Scholar
• Chroni E, Monastirli A, Tsambaos D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf. 2010;33(1):25–34. doi:10.2165/11319020-000000000-0000020000864
   PubMed Web of Science ®Google Scholar
• Balato N, Megna M, Palmisano F, et al. Psoriasis and sport: a new ally? J Eur Acad Dermatol Venereol. 2015;29(3):515–520. doi:10.1111/jdv.1260725132013
   PubMed Web of Science ®Google Scholar
• Larsabal M, Ly S, Sbidian E, et al. GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. Br J Dermatol. 2019;180(3):647–656. doi:10.1111/bjd.1714730188572
   PubMed Web of Science ®Google Scholar
• Lambe M, Bergstrom AV, Johansson ALV, Weibull CE. Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis-A population-based study. J Am Acad Dermatol. 2020;82(5):1109–1116. doi:10.1016/j.jaad.2019.05.09932029303
   PubMed Web of Science ®Google Scholar
• Cacciapuoti S, Scala E, Megna M, et al. Impact of current anti-psoriatic systemic treatments on male and female fertility: what the endocrinologist needs to know. Minerva Endocrinol. 2020. doi:10.23736/S0391-1977.20.03236-8
   Google Scholar
• Schuster B, Ziehfreund S, Biedermann T, Zink A. Psoriasis 2.0: facebook as a source of disease-related information for patients with psoriasis. J Dtsch Dermatol Ges. 2020;18(6):571–581.
   Google Scholar
• Amir M, Sampson BP, Endly D, et al. Social networking sites: emerging and essential tools for communication in dermatology. JAMA Dermatol. 2014;150(1):56–60. doi:10.1001/jamadermatol.2013.634024196212
   PubMed Web of Science ®Google Scholar
• Perkins S, Cohen JM, Nelson CA, Bunick CG. Teledermatology in the era of COVID-19: experience of an academic department of dermatology. J Am Acad Dermatol. 2020;83(1):e43–e44. doi:10.1016/j.jaad.2020.04.04832305442
   PubMed Web of Science ®Google Scholar
• Lavaud J, Mahé E. Proactive treatment in childhood psoriasis. Ann Dermatol Venereol. 2020;147(1):29–35. doi:10.1016/j.annder.2019.07.00531606260
   PubMed Web of Science ®Google Scholar
• Mahé E, Corgibet F, Maccari F, et al. Prescriptions hors AMM (autorisation de mise sur le marché) dans le psoriasis de l’enfant. Ann Dermatol Venereol. 2020;147(6–7):429–438. doi:10.1016/j.annder.2020.01.02132299624
   PubMed Web of Science ®Google Scholar
• Phan C, Beauchet A, Burztejn AC, et al. Biological treatments for paediatric psoriasis: a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. J Eur Acad Dermatol Venereol. 2019;33(10):1984–1992. doi:10.1111/jdv.1557930883928
   PubMed Web of Science ®Google Scholar
• Seyger M, Abramovits W, Liljedahl M, Hoejen MN, Teng J. Safety and efficacy of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <7 years) with plaque psoriasis: results of a Phase II, open-label trial. J Eur Acad Dermatol Venereol. 2020. doi:10.1111/jdv.16233
   Web of Science ®Google Scholar
• Charbit L, Mahé E, Phan A, et al. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children. Br J Dermatol. 2016;174(5):1118–1121. doi:10.1111/bjd.1432626617180
   PubMed Web of Science ®Google Scholar
• Bronckers IMGJ, Paller AS, West DP, et al. A comparison of psoriasis severity in pediatric patients treated with methotrexate vs biologic agents. JAMA Dermatol. 2020;156(4):384–392. doi:10.1001/jamadermatol.2019.483532022846
   PubMed Web of Science ®Google Scholar
• Bronckers IMGJ, Seyger MMB, West DP, et al. Safety of systemic agents for the treatment of pediatric psoriasis. JAMA Dermatol. 2017;153(11):1147–1157. doi:10.1001/jamadermatol.2017.302928903160
   PubMed Web of Science ®Google Scholar
• De Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62(6):1013–1030. doi:10.1016/j.jaad.2009.06.04819900732
   PubMed Web of Science ®Google Scholar
• Fortina AB, Bardazzi F, Berti S, et al. Treatment of severe psoriasis in children: recommendations of an Italian expert group. Eur J Pediatr. 2017;176(10):1339–1354. doi:10.1007/s00431-017-2985-x28836064
   PubMed Web of Science ®Google Scholar
• Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of dermatology-national psoriasis foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82(1):161–201. doi:10.1016/j.jaad.2019.08.04931703821
   PubMed Web of Science ®Google Scholar
• Eisert L, Augustin M, Bach S, et al. S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2. J Dtsch Dermatol Ges. 2019;17(9):959–973.
   Web of Science ®Google Scholar
• McClure SL, Valentine J, Gordon KB. Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf. 2002;25(13):913–927. doi:10.2165/00002018-200225130-0000312381213
   PubMed Web of Science ®Google Scholar
• Matos RS, Torres T. Facial hair growth in a patient with psoriasis. Aust Fam Physician. 2016;45(9):641–642.
   Google Scholar
• Man MQ, Ye L, Hu L, Jeong S, Elias PM, Lv C. Improvements in epidermal function prevent relapse of psoriasis: a self-controlled study. Clin Exp Dermatol. 2019;44(6):654–657. doi:10.1111/ced.1388830609089
   PubMed Web of Science ®Google Scholar
• Balak DMW, Gerdes S, Parodi A, Salgado-Boquete L. Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther (Heidelb). 2020;10(4):589–613. doi:10.1007/s13555-020-00409-432529393
   PubMed Web of Science ®Google Scholar
• Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358(3):241–251. doi:10.1056/NEJMoa06688618199863
   PubMed Web of Science ®Google Scholar
• Papp K, Thaçi D, Marcoux D, et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, Phase 3 trial. Lancet. 2017;390(10089):40–49. doi:10.1016/S0140-6736(17)31189-328478975
   PubMed Web of Science ®Google Scholar
• Landells I, Marano C, Hsu MC, et al. Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study. J Am Acad Dermatol. 2015;73(4):594–603. doi:10.1016/j.jaad.2015.07.00226259989
   PubMed Web of Science ®Google Scholar
• Paller AS, Seyger MMB, Alejandro Magariños G, et al. Efficacy and safety of ixekizumab in a Phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). Br J Dermatol. 2020;183(2):231–241. doi:10.1111/bjd.1914732316070
   PubMed Web of Science ®Google Scholar
• Summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/cosentyx-epar-product-information_en.pdf.
   Google Scholar